Revenue

Diamyd Medical's pivotal Phase 3 trial gets a nine-month acceleration, raising hopes for a new precision therapy that preserves insulin production.

Biomaterials firm Bolt Projects posts huge revenue gains and raises 2026 guidance, but a looming Nasdaq delisting threat casts a shadow on its future.

From industrial giant to boutique destination, discover how Yantai leveraged its unique climate to capture a third of China's wine market and global acclaim.

A major order for advanced semiconductor equipment will fuel a European firm's expansion, powering next-gen AI data centers and LiDAR systems.

Central Pattana invests 500M baht in a nationwide New Year's spectacle, featuring a digital stage, drone show, and massive fireworks to woo tourists.

In a market roiled by price wars, JA Solar's rise to No. 1 signals a new era of leadership defined by resilience, technology, and bankability.

A top phone maker is ditching physical sensors for AI software in 20+ models. Discover how this invisible tech revolution is changing smartphone design.

Everybody Loves Languages' CEO and CFO are taking the company private, raising questions about minority shareholder value and the firm's future strategy.

An FDA setback for its new mastitis drug prompts ImmuCell to double down on its profitable calf health franchise, First Defense®, in a major strategic shift.

Modular innovator Boxabl has secured a pivotal commercial license in California, fueling its expansion and pivot to commercial projects ahead of a SPAC merger.

The cardiac device innovator adds seasoned sales and operations executives to prepare its novel cryoablation technology for the global market.

Croatian firm Orqa is building a global network to produce one million drones annually, challenging market leaders and securing allied defense supply chains.

Tevogen's Dr. Ryan Saadi donates over $88,000 in company stock to a UN-recognized charity, bolstering educational programs for underserved children.

With just days until Christmas, CINCOM unveils discounted wellness bundles. The move tests the market's appetite for last-minute practical gifts.

A new cell-free therapy for the fatal lung disease IPF is heading to clinical trials, thanks to a key manufacturing partnership. Here's what it means.

Chinese insurtech Huize is cutting back on financial reports to focus on strategy, but its latest data shows a complex picture of soaring premiums and slowing new user growth.

American Express has locked in its 2026 earnings call schedule. Here’s what investors and analysts will be watching for amid shifting economic signals.

Global asset manager Patria Investments creates a new COO role and shuffles its finance leadership in a strategic move to scale operations globally.

Global marine supplier Wrist Group buys century-old Delaware Ship Supply, consolidating its power on the U.S. East Coast and ushering in a digital future.

Ursa Space Systems has been selected for the MDA's $151B SHIELD contract, signaling a new era of AI-driven satellite intelligence for homeland defense.